Efficacy of Erandadi taila karnapurana alone and along with Rasnadi churna orally in the management of Badhirya i.e. (Presbycusis)

Evaluation of the efficacy of Erandadi taila karnapurana alone and along with Rasnadi churna orally in the management of Badhirya (Presbycusis) - an open label double arm randomised comparative clinical trial - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076999

Enrollment

Registered

2024-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H911- Presbycusis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age between 50 to 75 years of age. 2. Patient having mild to moderate hearing loss (26- 60 dB). 3. Patients presenting with sign and symptoms of presbycusis.

Exclusion criteria

Exclusion criteria: 1.Patients with ear disease other than SNHL 2.Participants associated with tympanic membrane perforation. 3.Patients with severe degree of hearing impairment greater than 60dB. 4.Patients with otorrhoea. 5.Patients with congenital hearing loss. 6.Patients who require surgical intervention. 7.Individuals of SNHL secondary to other diseases like carcinoma, TB etc 8.Uncontrolled diabetes HbA1c greater than 8 percent 9.Uncontrolled hypertension i.e.Systolic BP greater than 140 mmHg and Diastolic BP greater than 90 mmHg.

Design outcomes

Primary

Measure	Time frame
changes in badhirya (difficulty in hearing) of the patient assessed by using pure tone audiometry.Timepoint: changes in badhirya (difficulty in hearing) of the patient assessed by using pure tone audiometry i.e. at baseline & 45th day	—

Secondary

Measure	Time frame
1.changes in other related signs & symptoms like tinnitus(karnanada), vertigo (bhrama) using grading scales. 2. change in quality of life of the patients using a questionare.Timepoint: baseline, 45th day	—

Countries

India

Contacts

Public ContactDr Ravi

All India Institute Of Ayurveda

drankuraiia@gmail.com8795297571

Outcome results